abstract
- Study Description: A Phase 3 open-label extension (OLE) study to evaluate the long-term safety and efficacy of ralinepag in subjects with World Health Organization (WHO) Group 1 pulmonary arterial hypertension (PAH)
APD811-303 Study Title: A StuDy EVAluatiNg the Long-Term EffiCacy and Safety of RalinEpag in Subjects with PAH via an Open-Label EXTENSION
Grant
Overview
date/time interval
- May 2020 - July 2024
awarded by
Affiliation
contributor
- Veeranna Maddipati Principal Investigator